Annual EBITDA
$9.74 M
+$20.04 M+194.57%
December 31, 2023
Summary
- As of February 7, 2025, VCYT annual EBITDA is $9.74 million, with the most recent change of +$20.04 million (+194.57%) on December 31, 2023.
- During the last 3 years, VCYT annual EBITDA has risen by +$36.48 million (+136.44%).
- VCYT annual EBITDA is now at all-time high.
Performance
VCYT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$22.73 M
+$9.63 M+73.49%
September 30, 2024
Summary
- As of February 7, 2025, VCYT quarterly EBITDA is $22.73 million, with the most recent change of +$9.63 million (+73.49%) on September 30, 2024.
- Over the past year, VCYT quarterly EBITDA has increased by +$33.36 million (+313.76%).
- VCYT quarterly EBITDA is now at all-time high.
Performance
VCYT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$28.88 M
+$45.17 M+277.19%
September 30, 2024
Summary
- As of February 7, 2025, VCYT TTM EBITDA is $28.88 million, with the most recent change of +$45.17 million (+277.19%) on September 30, 2024.
- Over the past year, VCYT TTM EBITDA has increased by +$64.78 million (+180.42%).
- VCYT TTM EBITDA is now at all-time high.
Performance
VCYT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VCYT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +194.6% | +313.8% | +180.4% |
| 3 y3 years | +136.4% | +344.9% | +145.9% |
| 5 y5 years | +156.9% | +7604.1% | +470.0% |
VCYT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +115.8% | at high | +201.3% | at high | +146.7% |
| 5 y | 5-year | at high | +115.8% | at high | +152.8% | at high | +145.9% |
| alltime | all time | at high | +115.8% | at high | +152.8% | at high | +145.9% |
Veracyte EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $22.73 M(+73.5%) | $28.88 M(-277.2%) |
| Jun 2024 | - | $13.10 M(+255.8%) | -$16.30 M(-47.1%) |
| Mar 2024 | - | $3.68 M(-134.6%) | -$30.81 M(-14.2%) |
| Dec 2023 | $9.74 M(-194.6%) | -$10.63 M(-52.6%) | -$35.91 M(+62.1%) |
| Sep 2023 | - | -$22.45 M(+1486.4%) | -$22.16 M(+907.5%) |
| Jun 2023 | - | -$1.42 M(+0.1%) | -$2.20 M(-43.2%) |
| Mar 2023 | - | -$1.41 M(-145.3%) | -$3.87 M(-62.4%) |
| Dec 2022 | -$10.30 M(-83.3%) | $3.12 M(-225.3%) | -$10.30 M(-43.6%) |
| Sep 2022 | - | -$2.49 M(-19.3%) | -$18.27 M(-27.1%) |
| Jun 2022 | - | -$3.08 M(-60.7%) | -$25.06 M(-5.8%) |
| Mar 2022 | - | -$7.85 M(+61.8%) | -$26.60 M(-57.0%) |
| Dec 2021 | -$61.81 M(+131.2%) | -$4.85 M(-47.7%) | -$61.81 M(-1.8%) |
| Sep 2021 | - | -$9.28 M(+100.5%) | -$62.93 M(+12.9%) |
| Jun 2021 | - | -$4.63 M(-89.3%) | -$55.73 M(-7.3%) |
| Mar 2021 | - | -$43.06 M(+621.9%) | -$60.11 M(+124.8%) |
| Dec 2020 | -$26.74 M(+242.5%) | -$5.96 M(+186.9%) | -$26.74 M(-0.5%) |
| Sep 2020 | - | -$2.08 M(-76.9%) | -$26.87 M(+9.7%) |
| Jun 2020 | - | -$9.00 M(-7.1%) | -$24.49 M(+45.6%) |
| Mar 2020 | - | -$9.69 M(+58.9%) | -$16.82 M(+115.6%) |
| Dec 2019 | -$7.80 M(-54.4%) | -$6.10 M(-2166.4%) | -$7.80 M(+135.9%) |
| Sep 2019 | - | $295.00 K(-122.1%) | -$3.31 M(-49.8%) |
| Jun 2019 | - | -$1.33 M(+99.6%) | -$6.59 M(-34.3%) |
| Mar 2019 | - | -$669.00 K(-58.2%) | -$10.04 M(-41.4%) |
| Dec 2018 | -$17.12 M | -$1.60 M(-46.5%) | -$17.12 M(-22.1%) |
| Sep 2018 | - | -$2.99 M(-37.4%) | -$21.97 M(-9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$4.78 M(-38.3%) | -$24.22 M(-3.1%) |
| Mar 2018 | - | -$7.75 M(+20.0%) | -$24.99 M(+5.2%) |
| Dec 2017 | -$23.76 M(-5.5%) | -$6.46 M(+23.2%) | -$23.76 M(+18.8%) |
| Sep 2017 | - | -$5.24 M(-5.5%) | -$19.99 M(+7.0%) |
| Jun 2017 | - | -$5.55 M(-14.9%) | -$18.69 M(-17.5%) |
| Mar 2017 | - | -$6.51 M(+142.4%) | -$22.66 M(-9.9%) |
| Dec 2016 | -$25.14 M(-19.1%) | -$2.69 M(-31.8%) | -$25.14 M(-14.4%) |
| Sep 2016 | - | -$3.94 M(-58.6%) | -$29.36 M(-12.7%) |
| Jun 2016 | - | -$9.52 M(+5.8%) | -$33.63 M(+3.4%) |
| Mar 2016 | - | -$9.00 M(+30.3%) | -$32.51 M(+6.0%) |
| Dec 2015 | -$31.07 M(+11.9%) | -$6.91 M(-15.9%) | -$30.68 M(-2.5%) |
| Sep 2015 | - | -$8.21 M(-2.3%) | -$31.48 M(+2.3%) |
| Jun 2015 | - | -$8.40 M(+17.2%) | -$30.77 M(+7.5%) |
| Mar 2015 | - | -$7.17 M(-6.9%) | -$28.63 M(+3.1%) |
| Dec 2014 | -$27.76 M(+14.0%) | -$7.70 M(+2.7%) | -$27.76 M(+8.6%) |
| Sep 2014 | - | -$7.50 M(+19.6%) | -$25.57 M(+6.7%) |
| Jun 2014 | - | -$6.26 M(-0.5%) | -$23.96 M(+0.0%) |
| Mar 2014 | - | -$6.30 M(+14.4%) | -$23.95 M(-1.6%) |
| Dec 2013 | -$24.35 M(+35.7%) | -$5.51 M(-6.5%) | -$24.35 M(+3.6%) |
| Sep 2013 | - | -$5.89 M(-5.9%) | -$23.50 M(+5.0%) |
| Jun 2013 | - | -$6.25 M(-6.6%) | -$22.37 M(+38.8%) |
| Mar 2013 | - | -$6.70 M(+43.8%) | -$16.12 M(+71.1%) |
| Dec 2012 | -$17.94 M(+29.7%) | -$4.66 M(-2.2%) | -$9.42 M(+97.8%) |
| Sep 2012 | - | -$4.76 M | -$4.76 M |
| Dec 2011 | -$13.83 M | - | - |
FAQ
- What is Veracyte annual EBITDA?
- What is the all time high annual EBITDA for Veracyte?
- What is Veracyte annual EBITDA year-on-year change?
- What is Veracyte quarterly EBITDA?
- What is the all time high quarterly EBITDA for Veracyte?
- What is Veracyte quarterly EBITDA year-on-year change?
- What is Veracyte TTM EBITDA?
- What is the all time high TTM EBITDA for Veracyte?
- What is Veracyte TTM EBITDA year-on-year change?
What is Veracyte annual EBITDA?
The current annual EBITDA of VCYT is $9.74 M
What is the all time high annual EBITDA for Veracyte?
Veracyte all-time high annual EBITDA is $9.74 M
What is Veracyte annual EBITDA year-on-year change?
Over the past year, VCYT annual EBITDA has changed by +$20.04 M (+194.57%)
What is Veracyte quarterly EBITDA?
The current quarterly EBITDA of VCYT is $22.73 M
What is the all time high quarterly EBITDA for Veracyte?
Veracyte all-time high quarterly EBITDA is $22.73 M
What is Veracyte quarterly EBITDA year-on-year change?
Over the past year, VCYT quarterly EBITDA has changed by +$33.36 M (+313.76%)
What is Veracyte TTM EBITDA?
The current TTM EBITDA of VCYT is $28.88 M
What is the all time high TTM EBITDA for Veracyte?
Veracyte all-time high TTM EBITDA is $28.88 M
What is Veracyte TTM EBITDA year-on-year change?
Over the past year, VCYT TTM EBITDA has changed by +$64.78 M (+180.42%)